Company · Ownership research

BELITE BIO, INC BLTE

CIK 0001889109

Form 4 transactions dated Oct 1, 2023 to Oct 16, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Sep 9, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $40.54M

Oct 1, 2023 – Sep 9, 2026
Available records · partial months are marked ·

202610 of 28 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Sep 8, 2026	Lin Yu-Hsin Chief Executive Officer · Director	Sale10b5-1 footnote	$5.11M 26,000 shares sold	27.05% sold Direct holding	▾
Sep 8, 2026	Chuang Hao-Yuan Chief Financial Officer · Director	Sale10b5-1 footnote	$3.53M 17,962 shares sold	40.82% sold Direct holding	▾
Sep 4, 2026	Lin Yu-Hsin Chief Executive Officer · Director	Sale10b5-1 footnote	$13.97M 74,435 shares sold	43.64% sold Direct holding	▾
Sep 4, 2026	Chuang Hao-Yuan Chief Financial Officer · Director	Sale10b5-1 footnote	$9.28M 49,433 shares sold	52.91% sold Direct holding	▾
Aug 12, 2026	Chuang Hao-Yuan Chief Financial Officer · Director	Sale10b5-1 footnote	$66.19K 367 shares sold	0.39% sold Direct holding	▾
Aug 12, 2026	Lin Yu-Hsin Chief Executive Officer · Director	Sale10b5-1 footnote	$65.83K 365 shares sold	0.21% sold Direct holding	▾
Jun 18, 2026	Scholl Hendrik Peter Chief Medical Officer	Sale	$1.45M 10,000 shares sold	40.00% sold Indirect holding	▾
Jun 16, 2026	Scholl Hendrik Peter Chief Medical Officer	Sale	$1.41M 10,000 shares sold	28.57% sold Indirect holding	▾
May 7, 2026	MATA NATHAN L. Chief Scientific Officer	Sale10b5-1 footnote	$102.04K 666 shares sold	100.00% sold Direct holding	▾
May 6, 2026	MATA NATHAN L. Chief Scientific Officer	Sale10b5-1 footnote	$153.84K 1,000 shares sold	60.02% sold Direct holding	▾

Showing 28 / 28 record groups in 2026. The complete set is available through the API.

BELITE BIO, INC · BLTE

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 28 of 28 purchase / sale groups and 7 of 7 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"BLTE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.